Clinical Translation of Neutrophil Imaging and Its Role in Cancer.

Autor: Lau D; Department of Radiology, University of Cambridge, Cambridge, UK. doreen.lau@oncology.ox.ac.uk.; Cancer Research UK Cambridge Centre, Cambridge, UK. doreen.lau@oncology.ox.ac.uk.; Department of Oncology, University of Oxford, Oxford, UK. doreen.lau@oncology.ox.ac.uk., Lechermann LM; Cancer Research UK Cambridge Centre, Cambridge, UK., Gallagher FA; Department of Radiology, University of Cambridge, Cambridge, UK. fag1000@cam.ac.uk.; Cancer Research UK Cambridge Centre, Cambridge, UK. fag1000@cam.ac.uk.
Jazyk: angličtina
Zdroj: Molecular imaging and biology [Mol Imaging Biol] 2022 Apr; Vol. 24 (2), pp. 221-234. Date of Electronic Publication: 2021 Oct 12.
DOI: 10.1007/s11307-021-01649-2
Abstrakt: Neutrophils are the first line of defense against pathogens and abnormal cells. They regulate many biological processes such as infections and inflammation. Increasing evidence demonstrated a role for neutrophils in cancer, where different subpopulations have been found to possess both pro- or anti-tumorigenic functions in the tumor microenvironment. In this review, we discuss the phenotypic and functional diversity of neutrophils in cancer, their prognostic significance, and therapeutic relevance in human and preclinical models. Molecular imaging methods are increasingly used to probe neutrophil biology in vivo, as well as the cellular changes that occur during tumor progression and over the course of treatment. This review will discuss the role of neutrophil imaging in oncology and the lessons that can be drawn from imaging in infectious diseases and inflammatory disorders. The major factors to be considered when developing imaging techniques and biomarkers for neutrophils in cancer are reviewed. Finally, the potential clinical applications and the limitations of each method are discussed, as well as the challenges for future clinical translation.
(© 2021. Crown.)
Databáze: MEDLINE
Externí odkaz: